Related Experiment Video
Updated: Feb 16, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
The prothrombotic state in paroxysmal nocturnal hemoglobinuria: a multifaceted source
Barnaby Peacock-Young1, Fraser L Macrae1, Darren J Newton2
1Thrombosis and Tissue Repair Group, Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, UK.
Paroxysmal nocturnal hemoglobinuria (PNH) increases thrombosis risk through complement-mediated mechanisms. This review explores factors like platelet activation and impaired fibrinolysis contributing to PNH
Area of Science:
- Hematology
- Thrombosis Research
- Complement System
Background:
- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired hematologic disorder.
- Thrombosis is the most serious complication of PNH, with mechanisms not fully understood.
- Unlike other thrombotic disorders, PNH thrombosis is predominantly complement-mediated.
Purpose of the Study:
- To review and discuss factors contributing to the increased thrombosis risk in PNH.
- To elucidate the complex prothrombotic state in PNH.
- To highlight the role of complement-mediated mechanisms in PNH-related thrombosis.
Main Methods:
- Literature review of existing studies on PNH and thrombosis.
- Analysis of pathological effects contributing to a prothrombotic state.
- Discussion of impaired fibrinolysis and its potential causes.
Main Results:
- PNH induces a multifaceted prothrombotic state via platelet activation, intravascular hemolysis, and neutrophil/monocyte activation.
- Platelet/endothelial microparticles and oxidative stress may contribute to thrombosis risk.
- Impaired fibrinolysis is observed, potentially linked to complement activation, coagulation, and fibrinolysis interactions.
Conclusions:
- Multiple factors contribute to thrombosis in PNH, but their relative importance is unclear.
- Further research using novel in vivo and in vitro models is needed.
- Clarifying complement-driven prothrombotic mechanisms and impaired fibrinolysis in PNH is crucial.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis I: Introduction
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

